The Global Trial Accelerators™ podcast (formerly known as LATAM Medtech Leaders) delivers actionable insights for Medtech, Biopharma, and Radiopharma innovators battling lengthy timelines and costly delays. Each episode features candid conversations with clinical trial pioneers, regulatory strategists, and startup founders who’ve slashed 6–12 months off approvals by leveraging emerging regions like Latin America, Eastern Europe, and Australia.
In this episode, we welcome Scott Stout, a leader focused on transforming access to clinical trials through innovative provider engagement models. Through HCP Recruitment, Scott and the team at MedVector are redefining how clinical trial sites connect with patients by unlocking access to larger, mo…
This episode features Scott Stout , who is helping reshape clinical trial recruitment through MedVector’s innovative HCP Recruitment model. By engaging community physicians in a new way, MedVector enables access to larger and...
In this episode, we welcome Matteo Talotta, a professional whose global and multidisciplinary background spans banking, academia, government, start-ups, scale-ups, and multinational corporations. Having worked across Canada, Italy, the United States, Spain, and Romania, Matteo brings a unique, firs…
This episode features Matteo Talotta , a global leader with experience across banking, academia, government, and a wide range of organizations — from start-ups and scale-ups to large multinationals. After working in Canada, I...
In today’s episode, we sit down with Sonal Pendharkar Kulkarni, Ph.D., Co-founder and CSO of Uvisa Health. With expertise spanning women’s health, the microbiome, digital health, and medical device innovation, Sonal is leading groundbreaking work that aims to transform how vaginal health is underst…
In this episode, we’re joined by Sonal Pendharkar Kulkarni, Ph.D. , Co-founder and Chief Science Officer at Uvisa Health . With a background that bridges women’s health, the microbiome, digital health innovation, and medical ...
In today's fast-paced business environment, building a high-performing team is paramount to achieving sustainable success. Nowhere is this truer than in the demanding world of private equity, where the stakes are high and the pressure to deliver exc…
Welcome to the blog! In this post, we'll be exploring the extraordinary career of Dr. Joseph Palumbo, a true pioneer in the fields of psychiatry, neurology, and neurodegenerative research. From his early work to his current role at BioVie, Dr. Palum…
Welcome to this blog post, a companion piece to our recent podcast episode featuring Nicholas Kadysh, CEO of PharmAla Biotech. In this episode, which you can listen to here, we delved into PharmAla Biotech's groundbreaking work in revolutionizing GM…
CEO, bioaccess®
Julio G. Martinez-Clark, CEO of bioaccess®, has spent over a decade dismantling barriers to Medtech, Biopharma, and Radiopharma innovation by positioning Latin America, Eastern Europe (the Balkans), and Australia as global leaders in clinical research. His work challenges entrenched perceptions of the region, transforms healthcare access for underserved populations, and reimagines how medical innovations reach commercialization. Through bioaccess®, Julio has created a blueprint for cost-effective, ethically rigorous clinical trials that accelerate time-to-market while elevating local communities.
Business Development Director, bioaccess®
Jesus E. Moreno is a business development director who provides efficient and reliable clinical research services in Latin America. With a passion for driving innovation in the healthcare sector, Jesus leverages his bilingual biomedical engineering background and his understanding of the unique challenges that Medtech startups face to provide valuable support and deliver accelerated clinical study results. Jesus profoundly understands the critical role that reliable and streamlined clinical research plays in the success of Medtech startups. He firmly believes that by offering cost-effective solutions without compromising quality, Medtech startups can achieve their clinical goals faster and make a meaningful impact in the healthcare industry. Jesus is passionate about supporting Medtech startups in their journey towards bringing innovative medical technologies to market. Jesus possesses the technical expertise to understand the complexities of medical devices and technologies. This knowledge enables him to identify tailored solutions that meet the specific needs of Medtech startups. Jesus has a bachelor's degree in biomedical engineering and a master's degree in electronics engineering.